LY3143921 hydrate
LY3143921 hydrate is a potent and orally bioavailable CDC7 kinase inhibitor. It demonstrates broad-spectrum anticancer activity in vitro and has shown efficacy in preclinical in vivo tumor models, supporting its investigation in cancer research, particularly in DNA replication and cell cycle studies.
Product Specifications
CAS Number
1627696-53-0
Product Name Alternative
CDC7, LY 3143921 Hydrate, LY3143921 Hydrate, LY3143921 hydrate, LY-3143921 hydrate, LY-3143921 Hydrate
Field of Research
Cell Biology
Purity
95.28% (May vary between batches)
Solubility
DMSO:65 mg/mL (198.59 mM) ; Ethanol:32 mg/mL (97.77 mM)
Smiles
C[C@]1 (C2=C (C=C (C=C2) C3=CNN=C3) C (=O) N1) C4=NC=NC=C4F.O
Molecular Formula
C16H14FN5O2
Molecular Weight
327.31
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15104378 1 Vial
Lentiviral mouse Slamf7 shRNA (UAS) - Lentiviral mouse Slamf7 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
GTR15176120 1 Vial
Lentiviral mouse Efhb shRNA (UAS) - Lentiviral mouseEfhb shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 